Pharmafile Logo
Pharmafocus logo
Advanced Search

acquisition

Showing 15 posts of 94 posts found.

J&J reportedly poised to acquire Europe’s biggest biotech

November 25, 2016
Sales and Marketing Actelion, J&J, JJ, Johnson and Johnson, acquisition

Johnson & Johnson could be eyeing a takeover of Swiss biotech Actelion, Europe’s biggest biotech, according to insiders, Bloomberg has …

News

Abbott-St. Jude $25 billion deal close to clearance

November 16, 2016
Research and Development, Sales and Marketing Abbott, St. Jude, acquisition

EU antitrust regulators are due to reach a decision on the deal on 23 November that would see Abbott Laboratories …

News

ICU Medical to acquire Pfizer’s global infusion therapy business in $1 billion deal

October 6, 2016
Medical Communications Hospira, ICU medical, Pfizer, acquisition, infusion

The $1 billion deal that will take place as ICU Medical Inc. take over Pfizer’s Hospira Infusion Systems will be …

News
celgene_1_02

$600m acquisition bolsters Celgene’s blood cancer portfolio

October 3, 2016
Manufacturing and Production, Research and Development Celgene, EngMab, acquisition, lymphoma, multiple myeloma

Celgene has shelled out $600m for Swiss biotech EngMab in an effort to reinforce its blood cancer portfolio with a …

News
jj_sign_on_wall

J&J in $4.33bn eye surgery unit acquisition

September 19, 2016
Manufacturing and Production, Sales and Marketing Abbott, Johnson & Johnson, acquisition

Johnson & Johnson has agreed to buy Abbott Laboratories’ eye surgery equipment unit in an all-cash deal for £4.33 billion …

News
shutterstock_512649

Dechra signs £31 million acquisition

September 16, 2016
Medical Communications Apex Laboratories, Dechra, acquisition

Dechra has agreed a deal to acquire veterinary pharmaceutical company Australian firm Apex Laboratories for AUS $55 (£31.3) million. The …

News
allergan

Allergan snaps up Vitae Pharma for $639 million

September 15, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Vitae, acquisition

Allergan has agreed to buy clinical-stage biotech Vitae Pharmaceuticals for $639 million, or $21 a share – more than double …

News
shutterstock_273326141

Horizon buys out Raptor for $800 million

September 13, 2016
Manufacturing and Production, Sales and Marketing Horizon Pharma, Raptor Pharmaceutical, acquisition

Irish biopharmaceutical firm Horizon Pharma has finalised an $800 million deal to buy Raptor Pharmaceutical Corp in a bid to …

News

Bayer ponders $1.1 billion portfolio sale to fund Monsanto acquisition

September 12, 2016
Business Services, Manufacturing and Production, Sales and Marketing Bayer, acquisition, monsanto

In the latest development in the Bayer-Monsanto saga, the German drugmaker has enlisted the aid of global financial services firm …

News
allergan

Allergan acquires biotech Retrosense for $60 million

September 7, 2016
Research and Development, Sales and Marketing Allergan, Retrosense, acquisition

Allergan has announced that it has acquired Retrosense, a biotech focused on novel gene therapy approaches to restore vision in …

News

Pfizer acquires Medivation for $14 billion

August 22, 2016
Sales and Marketing Medivation, Pfizer, acquisition, oncology

Pfizer has sealed the deal to acquire US cancer drug company Medivation for close to $14 billion in a move …

News
allergan

Allergan set to acquire eye-care biotech ForSight VISION5

August 12, 2016
Medical Communications, Sales and Marketing Allergan, ForSight VISION5, acquisition, biotech, eye care

Allergan has announced its acquisition of privately-held, clinical-stage eye-care biotech ForSight VISION5 for a $95 million upfront payment and a …

News
pfizer_credit_flickr__ceiling

Pfizer expands gene therapy operations with acquisition of Bamboo Therapeutics

August 2, 2016
Manufacturing and Production, Research and Development Pfizer, acquisition, bamboo therapeutics, gene therapy

Pfizer has announced that it has acquired gene therapy biotech Bamboo Therapeutics for an initial $150 million, with potential milestone …

News

China’s Fosun seals $1.3 billion deal for Gland Pharma

July 29, 2016
Medical Communications, Sales and Marketing acquisition, fosun, gland, takeover

Fosun Pharmaceutical has agreed a deal to purchase an 86.1% stake of Gland Pharma, which will see the Chinese firm …

News
shirelabsus

Shire adds to gastrointestinal portfolio with Pfizer compound acquisition

June 14, 2016
Research and Development, Sales and Marketing Pfizer, Shire, acquisition, compound

Shire (LSE: SHP) has announced that it has acquired an investigational biologic for the treatment inflammatory bowel disease from Pfizer …

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023